FDA.reportPublic FDA data

Application 209839

Type
ANDA
Sponsor
CIPLA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SOLIFENACIN SUCCINATESOLIFENACIN SUCCINATETABLET;ORAL5MGNoNo
002SOLIFENACIN SUCCINATESOLIFENACIN SUCCINATETABLET;ORAL10MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
69097-259SOLIFENACINE SUCCINATEsolifenacine succinateCipla USA Inc.ANDACurrent
69097-259SOLIFENACINE SUCCINATEsolifenacine succinateCipla USA Inc.ANDACurrent
69097-259SOLIFENACINE SUCCINATEsolifenacine succinateCipla USA Inc.ANDACurrent
69097-261SOLIFENACINE SUCCINATEsolifenacine succinateCipla USA Inc.ANDACurrent
69097-261SOLIFENACINE SUCCINATEsolifenacine succinateCipla USA Inc.ANDACurrent
69097-261SOLIFENACINE SUCCINATEsolifenacine succinateCipla USA Inc.ANDACurrent